AAPL294.09+4.73 (+1.63%) ▲|ABBV250.46-1.18 (-0.47%) ▼|ABT91.99+1.25 (+1.38%) ▲|ACN133.69+9.25 (+7.43%) ▲|ADBE211.66+6.64 (+3.24%) ▲|AMAT642.79-80.22 (-11.09%) ▼|AMD550.87-30.04 (-5.17%) ▼|AMGN358.85-3.27 (-0.90%) ▼|AMT167.08+3.51 (+2.15%) ▲|AMZN244.01+5.67 (+2.38%) ▲|AVGO369.88-7.88 (-2.08%) ▼|AXP348.36+10.11 (+2.99%) ▲|BA217.42+0.95 (+0.44%) ▲|BAC58.31+1.33 (+2.33%) ▲|BKNG184.07+5.83 (+3.27%) ▲|BLK979.29+17.73 (+1.84%) ▲|BMY56.35-1.28 (-2.21%) ▼|BNY146.80+2.19 (+1.51%) ▲|BRK-B502.27+1.88 (+0.38%) ▲|C139.73-0.24 (-0.17%) ▼|CAT995.45-69.45 (-6.52%) ▼|CL92.18+0.50 (+0.55%) ▲|CMCSA24.09-0.47 (-1.89%) ▼|COF203.87+3.25 (+1.62%) ▲|COP103.55-0.41 (-0.39%) ▼|COST925.88-9.60 (-1.03%) ▼|CRM164.60+7.94 (+5.07%) ▲|CSCO116.40-1.06 (-0.90%) ▼|CVS104.62+1.17 (+1.13%) ▲|CVX166.22+0.46 (+0.28%) ▲|DE628.68-5.65 (-0.89%) ▼|DHR193.65+3.17 (+1.66%) ▲|DIS96.53+0.28 (+0.29%) ▲|DUK125.55-1.04 (-0.82%) ▼|EMR140.56-2.60 (-1.81%) ▼|FDX315.06+1.93 (+0.62%) ▲|GD362.21+7.97 (+2.25%) ▲|GE371.57-2.16 (-0.58%) ▼|GEV1,138.85-36.01 (-3.07%) ▼|GILD126.08-0.26 (-0.21%) ▼|GM75.52-1.57 (-2.03%) ▼|GOOG356.07+2.74 (+0.77%) ▲|GOOGL359.17+1.80 (+0.50%) ▲|GS1,024.54+13.17 (+1.30%) ▲|HD353.46+0.78 (+0.22%) ▲|HON220.93-2.97 (-1.33%) ▼|IBM289.18+7.97 (+2.83%) ▲|INTC128.11-11.53 (-8.25%) ▼|INTU270.19+9.19 (+3.52%) ▲|ISRG401.91+4.23 (+1.06%) ▲|JNJ252.47-1.51 (-0.59%) ▼|JPM333.67+6.34 (+1.94%) ▲|KO81.40+0.13 (+0.15%) ▲|LIN536.36+17.42 (+3.36%) ▲|LLY1,175.64-23.79 (-1.98%) ▼|LMT517.91+8.45 (+1.66%) ▲|LOW223.14+2.65 (+1.20%) ▲|LRCX386.96-46.37 (-10.70%) ▼|MA526.21+12.61 (+2.46%) ▲|MCD271.02+0.71 (+0.26%) ▲|MDLZ58.73+0.89 (+1.53%) ▲|MDT78.92+0.69 (+0.88%) ▲|META622.54+59.25 (+10.52%) ▲|MMM160.87-1.04 (-0.64%) ▼|MO72.17+0.22 (+0.30%) ▲|MRK126.10-2.41 (-1.87%) ▼|MS211.85+2.81 (+1.34%) ▲|MSFT387.67+14.65 (+3.93%) ▲|MU1,044.93-109.37 (-9.47%) ▼|NEE86.73-1.04 (-1.18%) ▼|NFLX74.01+2.61 (+3.66%) ▲|NKE42.02+0.97 (+2.35%) ▲|NOW106.39+7.11 (+7.16%) ▲|NVDA198.75-1.35 (-0.67%) ▼|ORCL143.87-2.69 (-1.83%) ▼|PEP140.59+5.19 (+3.83%) ▲|PFE23.80-0.29 (-1.18%) ▼|PG146.10-0.54 (-0.37%) ▼|PLTR127.54+10.87 (+9.32%) ▲|PM179.59-1.32 (-0.73%) ▼|QCOM183.81-0.98 (-0.53%) ▼|RTX190.13+0.40 (+0.21%) ▲|SBUX103.42+1.23 (+1.20%) ▲|SCHW95.82+3.55 (+3.84%) ▲|SO95.23-0.48 (-0.50%) ▼|SPG221.12-2.53 (-1.13%) ▼|T20.64-0.06 (-0.28%) ▼|TMO514.97+13.61 (+2.71%) ▲|TMUS173.29+5.56 (+3.31%) ▲|TSLA426.19+5.59 (+1.33%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.24+1.08 (+1.50%) ▲|UNH425.67+10.04 (+2.42%) ▲|UNP278.20+6.20 (+2.28%) ▲|UPS110.08+2.58 (+2.40%) ▲|USB62.07+1.67 (+2.76%) ▲|V351.73+8.64 (+2.52%) ▲|VZ42.02-0.33 (-0.77%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.33-4.93 (-4.35%) ▼|XOM136.32-0.40 (-0.29%) ▼|AAPL294.09+4.73 (+1.63%) ▲|ABBV250.46-1.18 (-0.47%) ▼|ABT91.99+1.25 (+1.38%) ▲|ACN133.69+9.25 (+7.43%) ▲|ADBE211.66+6.64 (+3.24%) ▲|AMAT642.79-80.22 (-11.09%) ▼|AMD550.87-30.04 (-5.17%) ▼|AMGN358.85-3.27 (-0.90%) ▼|AMT167.08+3.51 (+2.15%) ▲|AMZN244.01+5.67 (+2.38%) ▲|AVGO369.88-7.88 (-2.08%) ▼|AXP348.36+10.11 (+2.99%) ▲|BA217.42+0.95 (+0.44%) ▲|BAC58.31+1.33 (+2.33%) ▲|BKNG184.07+5.83 (+3.27%) ▲|BLK979.29+17.73 (+1.84%) ▲|BMY56.35-1.28 (-2.21%) ▼|BNY146.80+2.19 (+1.51%) ▲|BRK-B502.27+1.88 (+0.38%) ▲|C139.73-0.24 (-0.17%) ▼|CAT995.45-69.45 (-6.52%) ▼|CL92.18+0.50 (+0.55%) ▲|CMCSA24.09-0.47 (-1.89%) ▼|COF203.87+3.25 (+1.62%) ▲|COP103.55-0.41 (-0.39%) ▼|COST925.88-9.60 (-1.03%) ▼|CRM164.60+7.94 (+5.07%) ▲|CSCO116.40-1.06 (-0.90%) ▼|CVS104.62+1.17 (+1.13%) ▲|CVX166.22+0.46 (+0.28%) ▲|DE628.68-5.65 (-0.89%) ▼|DHR193.65+3.17 (+1.66%) ▲|DIS96.53+0.28 (+0.29%) ▲|DUK125.55-1.04 (-0.82%) ▼|EMR140.56-2.60 (-1.81%) ▼|FDX315.06+1.93 (+0.62%) ▲|GD362.21+7.97 (+2.25%) ▲|GE371.57-2.16 (-0.58%) ▼|GEV1,138.85-36.01 (-3.07%) ▼|GILD126.08-0.26 (-0.21%) ▼|GM75.52-1.57 (-2.03%) ▼|GOOG356.07+2.74 (+0.77%) ▲|GOOGL359.17+1.80 (+0.50%) ▲|GS1,024.54+13.17 (+1.30%) ▲|HD353.46+0.78 (+0.22%) ▲|HON220.93-2.97 (-1.33%) ▼|IBM289.18+7.97 (+2.83%) ▲|INTC128.11-11.53 (-8.25%) ▼|INTU270.19+9.19 (+3.52%) ▲|ISRG401.91+4.23 (+1.06%) ▲|JNJ252.47-1.51 (-0.59%) ▼|JPM333.67+6.34 (+1.94%) ▲|KO81.40+0.13 (+0.15%) ▲|LIN536.36+17.42 (+3.36%) ▲|LLY1,175.64-23.79 (-1.98%) ▼|LMT517.91+8.45 (+1.66%) ▲|LOW223.14+2.65 (+1.20%) ▲|LRCX386.96-46.37 (-10.70%) ▼|MA526.21+12.61 (+2.46%) ▲|MCD271.02+0.71 (+0.26%) ▲|MDLZ58.73+0.89 (+1.53%) ▲|MDT78.92+0.69 (+0.88%) ▲|META622.54+59.25 (+10.52%) ▲|MMM160.87-1.04 (-0.64%) ▼|MO72.17+0.22 (+0.30%) ▲|MRK126.10-2.41 (-1.87%) ▼|MS211.85+2.81 (+1.34%) ▲|MSFT387.67+14.65 (+3.93%) ▲|MU1,044.93-109.37 (-9.47%) ▼|NEE86.73-1.04 (-1.18%) ▼|NFLX74.01+2.61 (+3.66%) ▲|NKE42.02+0.97 (+2.35%) ▲|NOW106.39+7.11 (+7.16%) ▲|NVDA198.75-1.35 (-0.67%) ▼|ORCL143.87-2.69 (-1.83%) ▼|PEP140.59+5.19 (+3.83%) ▲|PFE23.80-0.29 (-1.18%) ▼|PG146.10-0.54 (-0.37%) ▼|PLTR127.54+10.87 (+9.32%) ▲|PM179.59-1.32 (-0.73%) ▼|QCOM183.81-0.98 (-0.53%) ▼|RTX190.13+0.40 (+0.21%) ▲|SBUX103.42+1.23 (+1.20%) ▲|SCHW95.82+3.55 (+3.84%) ▲|SO95.23-0.48 (-0.50%) ▼|SPG221.12-2.53 (-1.13%) ▼|T20.64-0.06 (-0.28%) ▼|TMO514.97+13.61 (+2.71%) ▲|TMUS173.29+5.56 (+3.31%) ▲|TSLA426.19+5.59 (+1.33%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.24+1.08 (+1.50%) ▲|UNH425.67+10.04 (+2.42%) ▲|UNP278.20+6.20 (+2.28%) ▲|UPS110.08+2.58 (+2.40%) ▲|USB62.07+1.67 (+2.76%) ▲|V351.73+8.64 (+2.52%) ▲|VZ42.02-0.33 (-0.77%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.33-4.93 (-4.35%) ▼|XOM136.32-0.40 (-0.29%) ▼|
33.9 C
New York
Wednesday, July 1, 2026

Tag: medical

Medical Device Software Global Market Access Training Course | Explore Regulatory Pathways and Reimbursement Strategies Across Jurisdictions (ONLINE EVENT: September 8-9, 2025)

Master market access for medical device software with our expert-led course. Navigate international regulations, understand reimbursement pathways, and enhance commercial success globally. Gain insights with real-life examples and earn CPD certification. Join now to ensure market entry success!
Master market access for medical device software with our expert-led course. Navigate international regulations, understand reimbursement pathways, and enhance commercial success globally. Gain insights with real-life examples and earn CPD certification. Join now to ensure market entry success!

PathAI Receives FDA Clearance for AISight® Dx Platform for Primary Diagnosis

BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx*—its digital pathology image management system—for use in primary diagnosis in clinical settings. Building on the initial 510(k) clearance for AISight Dx(Novo) in 2022, this latest milestone underscores the platform’s continuous innovation and PathAI’s commitment to delivering enhanced capabilities as the product evolves.

Qiming Venture Partners’ Portfolio Company Unisound Successfully Lists on the Hong Kong Stock Exchange

SHANGHAI, June 30, 2025 /PRNewswire/ -- On June 30th, Beijing time, Unisound, a pioneer in the industrialization of AI technologies in China and a portfolio company...

HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line...

— Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy —

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Affidea Group selects b-rayZ as its preferred AI partner in breast imaging, marking strategic collaboration

THE HAGUE, The Netherlands, June 30, 2025 (GLOBE NEWSWIRE) -- In a strategic move to improve patient outcomes in breast cancer, Affidea, a leading pan-European provider of community-based polyclinics, specialist services and advanced diagnostics, is proud to announce that it has selected b-rayZ, a leader in AI-powered breast imaging solutions, as its preferred AI partner for breast imaging.

PlaDeo: Europe Debut for the World’s First Bio-Plasma Powered Deodorant Device

CES Award-Winning Korean Innovation Now Targets EU Consumers Seeking Safe and Sustainable Hygiene SEOUL, South Korea, June 30, 2025 /PRNewswire/ -- CodeSteri Inc., a bio-tech startup...

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

LUND, Sweden, June 30, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), announced today the presentation of its five year extended pooled...

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

LUND, Sweden, June 30, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), announced today the presentation of its five year extended pooled...

Online Payday Loans with Same Day Approval No Credit Check – Radcred Launches Instant Loan Platform for US Borrowers

Radcred offers same-day payday loans online with no credit check. Apply for instant payday loans today, even with bad credit, and get fast approval!
Radcred offers same-day payday loans online with no credit check. Apply for instant payday loans today, even with bad credit, and get fast approval!

No Credit Check Loans Explained: Low Credit Finance Releases U.S. Borrower Education Guide

The new borrower-focused guide from Low Credit Finance outlines how no credit check loans work, who qualifies, and what to expect during the U.S. application process.
The new borrower-focused guide from Low Credit Finance outlines how no credit check loans work, who qualifies, and what to expect during the U.S. application process.

ReadyPaydayLoans.com Launches “Ready Pay” App to Help Americans Access the Best Personal Loans by State with Same Day Results

Get same day results on payday loans, bad credit loans & no credit check loans in all 50 states with Ready Pay App at ReadyPaydayLoans.com.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedical